Key insights
- Proteomics technology is at an inflection point; researchers can detect many more molecules faster than ever before.
- Proteome researchers are capitalizing on artificial intelligence to enable multiomics, spatial and massive population studies, and some very large research initiatives are finding their feet.
- But the field faces some important questions, including how to be sure of what different tools are measuring, how research can best benefit human health, and how to coordinate worldwide efforts.
Singapore—“Proteins don’t exist,” quipped Bernd Wollscheid, treasurer of the Human Proteome Organization (HUPO), during a panel interview with several other HUPO leaders about the state of proteomics. “That’s our new slogan.”
“I wouldn’t go that far!” HUPO president Uwe Völker quickly countered.
